Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

A Continuation of a Timeline of Ivermectin-Related Events in the COVID-19 Pandemic [June 30, 2021]

Turkia, M., ResearchGate, doi:10.13140/RG.2.2.16973.36326
Jun 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now known with p < 0.00000000001 from 102 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19ivm.org
An extension of the ivermectin timeline covering April - June 2021, including WHO's role and funding, Gavi, COVAX, Trusted News Initiative, International Fact-Checking Network, the role of private philantrophy, Frontiers, comparison to the H1N1 pandemic, new treatment protocols, and causal modeling.
Turkia et al., 30 Jun 2021, preprint, 1 author.
This PaperIvermectinAll
A continuation of a timeline of ivermectin-related events in the COVID-19 pandemic
M.Sc Mika Turkia
This review presents a continuation of a previous timeline that described ivermectin-related events in the COVID-19 pandemic from April 2020 to the end of March 2021. The new timeline covers a period from the beginning of April 2021 to the end of June 2021. In April 2021, the US National Institutes of Health (NIH) announced a new, large clinical trial including ivermectin, with an estimated study completion date in March 2023. A large national trial was also announced in the Philippines, a 1,160-patient trial in the US, and another trial in Ireland. Trial results published in the period resembled those of previous trials, not producing clinically meaningful changes to the results of existing meta-analyses. Mainstream press of the high-income countries mostly repeated the same arguments as in the previous period, including the warnings against ivermectin by the European Medicine Agency (EMA) and the World Health Organization (WHO). The sparse and onesided coverage of ivermectin in the press appeared to result from a program called Trusted News Initiative (TNI). The censorship practices of the social media companies, with policies disallowing expression of views differing from the guidelines of the WHO, continued unchanged, apparently organized under a program called International Fact-Checking Network (IFCN). In contrast to the previous period -during which groups such as the Front Line COVID-19 Critical Care Alliance (FLCCC) and the British Ivermectin Recommendation Development (BIRD) group attempted to influence the decisions of government agencies -in this period these groups began to bypass the agencies and turn directly to clinicians and the public. FLCCC also published two new protocols, I-MASS for mass immunization, and I-RECOVER for long haul COVID-19 syndrome (LHCS), and a review article which by the end of the period had reached a position in the top 120 of 18 million articles tracked by Altmetric. The BIRD group organized two online conferences on ivermectin and published a meta-analysis which had reached a position in the top 60, respectively. One of the authors of the in vitro study that initiated the international interest in ivermectin explained that due to, for example, lack of adaptive immune responses in the cell model, their study was unsuitable for making conclusions about in vivo dosing in humans. A review described 20 mechanisms of action of ivermectin in COVID-19. The parties against and in favor of ivermectin remained in deeply conflicting positions, presenting opposite conclusions on the existing research. The WHO, along with regulatory agencies and national governments of high-income countries, appeared to aim at preserving the value of existing investments in vaccine and investigational therapeutics development, as well as questioning the efficacy and safety of repurposed medicines. Criticism towards excessive influence of Bill Gates in the WHO emerged during the period, as the largest funder of the WHO appeared to be a..
Authors' contributions The author was responsible for all aspects of the manuscript. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Ethics approval and consent to participate Not applicable. Consent for publication Not applicable. Competing interests The author declares that he has no competing interests. Author details Independent researcher, Helsinki, Finland. ORCID iD: 0000-0002-8575-9838
References
Abbasi, Covid-19: politicisation "corruption," and suppression of science, BMJ, doi:10.1136/bmj.m4425
Abd-Elsalam, Noor, Badawi, Khalaf, Esmail et al., Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study, Journal of Medical Virology, doi:10.1002/jmv.27122
Abdelgawad, Allam, Shaheen, Hussein, Elkot et al., An Overview of COVID-19 Treatment: Possible Candidates Based on Drug Repurposing and Molecular Docking, Canadian Journal of Medicine, doi:10.33844/cjm.2021.60499
Abeysinghe, Pandemics, science and policy: H1N1 and the World Health Organization, doi:10.1057/9781137467201
Abu-Sbaih, JAMA ivermectin study is fatally flawed
Alam, Mahmud, Rahman, Simpson, Aggarwal et al., Clinical outcomes of early treatment with doxycycline for 89 high-risk COVID-19 patients in long-term care facilities in, doi:10.7759/cureus.9658
Albertini, Sestili, Malone, Haimes, Resignation in protest
Alfonsi, Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant
Allen Foundation, About
Andris, Sudeepa Abeysinghe, pandemics, science and policy. H1N1 and the World Health Organization, doi:10.4000/lectures.19311
Androuët, World Health Organization's relationship with its private donors
Antoszczak, Markowska, Markowska, Huczyński, Old wine in new bottles: drug repurposing in oncology, European Journal of Pharmacology, doi:10.1016/j.ejphar.2019.172784
Araja, Ivermectin now on retail-solon
Aref, Bazeed, Hassan, Hassan, Hassan, Clinical biochemical and molecular evaluations of ivermectin mucoadhesive nanosuspension nasal spray in reducing upper respiratory symptoms of mild COVID-19, International Journal of Nanomedicine, doi:10.2147/ijn.s313093
Ashour, Ivermectin: From theory to clinical application, International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2019.05.003
Babalola, Bode, Ajayi, Alakaloko, Akase et al., Ivermectin shows clinical benefits in mild to moderate COVID19: a randomised controlled double-blind dose-response study in Lagos, QJM: An International Journal of Medicine, doi:10.1093/qjmed/hcab035
Balázs, Áttörés jön az ivermectin Covid-ellenes használatában
Bannister, Don't mention ivermectin; it'll upset the vaccine rollout
Bar, Legal notice to Dr, World Health Organisation Avenue Appia
Bartiromo, Sen, Johnson, Kory, on the impact of censorship in fight against COVID-19, FOX News Sunday Morning Futures
Bartlett, The worst 24 hours of my life': immunologist responds to Craig Kelly controversy
Bartoszko, Siemieniuk, Kum, Qasim, Zeraatkar et al., Prophylaxis against COVID-19: living systematic review and network meta-analysis, BMJ, doi:10.1136/bmj.n949
Behera, Patro, Padhy, Mohapatra, Bal et al., Prophylactic role of ivermectin in SARS-CoV-2 infection among healthcare workers, doi:10.21203/rs.3.rs-208785/v1
Behera, Patro, Singh, Chandanshive, Rk et al., Role of ivermectin in the prevention of COVID-19 infection among healthcare workers in India: a matched case-control study, medRxiv, doi:10.1101/2020.10.29.20222661
Behera, Patro, Singh, Chandanshive, Rs et al., Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: a matched case-control study. Adrish M, editor, PLOS ONE, doi:10.1371/journal.pone.0247163
Bello, Elucidation of the inhibitory activity of ivermectin with host nuclear importin a and several SARS-CoV-2 targets, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1911857
Beltran-Gonzalez, Gonzalez-Gamez, Mendoza-Enciso, Esparza-Maldonado, Hernanez-Palacios et al., Efficacy and safety of ivermectin and hydroxychloroquine in patients with severe COVID-19. A randomized controlled trial, doi:10.1101/2021.02.18.21252037
Berkley, Covax, None
Bhengu, Court order allows use of ivermectin for Covid-19 | News24
Bhorat, Bhorat, A qualitative analysis of seven ivermectin formulations in South Africa, South African Medical Journal
Bhowmick, Dang, Vallish, Dang, Safety and efficacy of ivermectin and doxycycline monotherapy and in combination in the treatment of COVID-19: a scoping review, doi:10.1007/s40264-021-01066-y
Bill, Gates Foundation, Global health leaders launch Decade of Vaccines collaboration
Bingham, The UK Government's Vaccine Taskforce: strategy for protecting the UK and the world, The Lancet, doi:10.1016/s0140-6736(20)32175-9
Birrell, Beijing's useful idiots
Blakely, Trial for Covid 'wonder drug' that could save thousands of lives, The Times
Bonsens, Actualités BonSens
Bossche, Cautious suggestions on a way out of a mismanaged Covid-19 pandemic
Bossche, Dvm, Geert, Bossche, None
Briquelet, Cartwright, Bill Gates thought Jeffrey Epstein was his ticket to a Nobel Prize
Broad, Billionaires with big ideas are privatizing American science
Brown, Ricci, Ottesen, Ivermectin: effectiveness in lymphatic filariasis, Parasitology, doi:10.1017/s0031182000006570
Bruno M De Los, De, Ivermectin reproposing for mild stage COVID-19 outpatients
Bryant, Lawrie, Dowswell, Fordham, Mitchell et al., Ivermectin for prevention and treatment of COVID-19 infection, American Journal of Therapeutics, doi:10.1097/mjt.0000000000001402
Bryant, Lawrie, Dowswell, Fordham, Scott et al., Ivermectin for prevention and treatment of COVID-19 infection: a systematic review and meta-analysis, doi:10.31219/osf.io/k37ft
Bryant, Lawrie, Dowswell, Fordham, Scott et al., Ivermectin for prevention and treatment of COVID-19 infection: a systematic review meta-analysis and trial sequential analysis to inform clinical guidelines, doi:10.31219/osf.io/dzs2v
Callahan, The givers: wealth, power, and philanthropy in a new gilded age
Caly, Druce, Catton, Jans, Wagstaff, The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Research, doi:10.1016/j.antiviral.2020.104787
Campbell, Goa, ivermectin for all adults
Campbell, Ivermectin and Malaria-Putting an Elderly Drug to a New Test. The American Journal of Tropical Medicine and Hygiene, doi:10.4269/ajtmh.19-0889
Campbell, Ivermectin discussion with Dr
Campbell, Ivermectin evidence with Dr Tess Lawrie: production price
Camprubí, Almuedo-Riera, Martí-Soler, Soriano, Hurtado et al., Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients. Dorlo TPC, editor, PLOS ONE. November, doi:10.1371/journal.pone.0242184
Capuzzo, New York Times best selling author Michael Capuzzo issues a plea to fellow journalists
Capuzzo, The drug that cracked Covid
Carpenter, Preventing regulatory capture: special interest influence and how to limit it
Cassim, Zimbabwe OKs use of ivermectin after officials' deaths
Castañeda-Sabogal, Chambergo-Michilot, Toro-Huamanchumo, Silva-Rengifo, Gonzales-Zamora et al., Outcomes of ivermectin in the treatment of COVID-19: a systematic review and meta-analysis, medRxiv, doi:10.1101/2021.01.26.21250420
Cathey, Timeline: tracking Trump alongside scientific developments on hydroxychloroquine
Chaccour, Hammann, Ramón-García, Rabinovich, Ivermectin and COVID-19: keeping rigor in times of urgency. The American Journal of Tropical, Medicine and Hygiene, doi:10.4269/ajtmh.20-0271
Chahla, Prophylaxis Covid-19 in healthcare agents by intensive treatment with ivermectin and iota-carrageenan
Chahla, Research protocol for reproposing of ivermectin in the treatment of mild stage patients with corona virus disease (COVID-19) in primary health care centers
Chahla, Ruiz, Mena, Brepe, Terranova et al., Cluster randomised trials -ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centers, doi:10.21203/rs.3.rs-495945%2Fv1
Chang, Figueredo, Post-acute and chronic COVID: therapeutic plan for patients with persistent symptoms of COVID
Chen, Bi, Wei, Zhao, Wang et al., Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma, Journal of Cellular and Molecular Medicine, doi:10.1111/jcmm.15195
Cheney, A: New PATH CEO on plans to become 'the go-to health NGO
Cheney, Big concerns' over Gates foundation's potential to become largest WHO donor
Chua, WHO's stand on Ivermectin to treat Covid-19
Clancy, m the virus expert cited by MP Craig Kelly. Vaccines are critical, but he's not all wrong
Clark, Ivermectin for Covid-19: a cheap drug with a remarkable effect
Clark, The impact of ivermectin use in Zimbabwe
Clarke, Covid-19: Who fact checks health and science on Facebook?, BMJ, doi:10.1136/bmj.n1170
Clarke, Public-private partnerships and responsibility under international law: a global health perspective
Clarke, Responsibility of hybrid public-private bodies under international law: a case study of global health public-private partnerships
Clarke, Why I'm volunteering to be infected with coronavirus
Cohen, Opinion -YouTube's censors get the science of medicine wrong, Wall Street Journal
Covid19crusher, Rubbish meta-analysis on ivermectin from Peru swaps the arm data from the key Niaee
Covidanalysis, An analysis of: Clinical trial of ivermectin plus doxycycline for the treatment of confirmed Covid-19 infection
Covidanalysis, Analysis of: A meta-analysis of mortality need for ICU admission, use of mechanical ventilation and adverse effects with ivermectin use in COVID-19 patients
Covidanalysis, Analysis of: Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors
Covidanalysis, Analysis of: Antiviral effect of high-dose ivermectin in adults with COVID-19: a proof-of-concept randomized trial
Covidanalysis, Analysis of: Clinical biochemical and molecular evaluations of ivermectin mucoadhesive nanosuspension nasal spray in reducing upper respiratory symptoms of mild COVID-19
Covidanalysis, Analysis of: Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
Covidanalysis, Analysis of: Comparative analytical study of two different drug regimens in treatment of Covid 19 positive patients in Index Medical College Hospital and Research Center
Covidanalysis, Analysis of: Effect of ivermectin on COVID-19: a multicenter double-blind randomized controlled clinical trial
Covidanalysis, Analysis of: Elucidation of the inhibitory activity of ivermectin with host nuclear importin α and several SARS-CoV-2 targets
Covidanalysis, Analysis of: Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
Covidanalysis, Analysis of: Ivermectin and COVID-19 in care home: case report
Covidanalysis, Analysis of: Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial
Covidanalysis, Analysis of: Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
Covidanalysis, Analysis of: Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: an open-label randomized trial
Covidanalysis, Analysis of: Retrospective cohort study of Ivermectin as a SARS-CoV-2 pre-exposure prophylactic method in healthcare workers
Covidanalysis, Global ivermectin adoption for COVID-19
Covidanalysis, Ivermectin for COVID-19: real-time analysis of all studies
Covidanalysis, Ivermectin for COVID-19: real-time meta analysis of 52 studies
Covidanalysis, Ivermectin for COVID-19: real-time meta analysis of 56 studies
Covidanalysis, Ivermectin is effective for COVID-19: real-time meta analysis
Covidanalysis, Ivermectin is effective for COVID-19: real-time meta analysis of 49 studies, Version
Covidanalysis, The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article
Covidanalysis, a pilot clinical trial in Lebanon
Covidanalysis, adults with mild COVID-19: a randomized clinical trial
Covidanalysis, analysis based on a public intervention in Mexico City
Crump, Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations, The Journal of Antibiotics, doi:10.1038/ja.2017.11
Cummins, professor Gordon Lauc -official pandemic advisor to Croatian government
Curtis, Gated development: is the Gates Foundation always a force for good? Global Justice Now
Danda, Šopfová, Ivermektin bude moci jít do všech lékáren
Dapat Izin, Sudah, Puluhan, Dosis, Moeldoko Cerita
Dawes, Who's advising WHO on the pandemic? Gleaner
Deng, Xu, Long, Xie, Suppressing ROS-TFE3-dependent autophagy enhances ivermectin-induced apoptosis in human melanoma cells, Journal of Cellular Biochemistry, doi:10.1002/jcb.27490
Dent, Ivermectin: why a potential COVID treatment isn't recommended for use
Diao, Cheng, Zhao, Xu, Dong et al., Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling, BMC Veterinary Research, doi:10.1186/s12917-019-2026-2
Dinicolantonio, Barroso-Aranda, Mccarty, Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors, Open Heart, doi:10.1136/openhrt-2021-001655
Doctor, Overview on all things ivermectin and COVID-19: guidance from new review article
Doidge, Medicine's fundamentalists
Domingo-Echaburu, Orive, Lertxundi, Ivermectin & COVID-19: let's keep a One Health perspective, Sustainable Chemistry and Pharmacy, doi:10.1016/j.scp.2021.100438
Dominguez-Gomez, Chavez-Blanco, Medina-Franco, Saldivar-Gonzalez, Flores-Torrontegui et al., Ivermectin as an inhibitor of cancer stem-like cells, Molecular Medicine Reports, doi:10.3892/mmr.2017.8231
Dominus, The Covid drug wars that pitted doctor vs. doctor
Dou, Chen, Wang, Yuan, Lei et al., Ivermectin induces cytostatic autophagy by blocking the PAK1/Akt axis in breast cancer, Cancer Research, doi:10.1158/0008-5472.can-15-2887
Doughton, Bill Gates: We must prepare for the next pandemic like we prepare for war
Dr, Tavárez Capellán, obtiene un descubrimiento médico que pudiera ser una panacea para la pandemia del COVID-19, Revista Médica
Dr, Tess Lawrie discusses her ivermectin meta-analysis
Dr, Ōmura, the discoverer of ivermectin, says a special approval should not be required
Draganov, Gopalakrishna-Pillai, Chen, Zuckerman, Moeller et al., Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death, Scientific Reports, doi:10.1038/srep16222
Draganov, Han, Bennett, Irvine, Lee, Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer. npj Breast Cancer, doi:10.1038/s41523-021-00229-5
Duneton, Statement for the G20 health ministers meeting
Ebrahim, Sohani, Montoya, Agarwal, Thorlund et al., Reanalyses of randomized clinical trial data, JAMA, doi:10.1001/jama.2014.9646
Eedee, Update on COVID-19 infection and ivermectin treatment, International Journal of Pathogen Research, doi:10.9734/ijpr/2021/v7i130172
Elgazzar, Eltaweel, Youssef, Hany, Hafez et al., Efficacy and safety of ivermectin for treatment and prophylaxis of COVID-19 pandemic, doi:10.21203/rs.3.rs-100956/v3
Elvir, Tratamiento catracho frena muertes exponenciales por COVID-19 en Honduras
Enserink, Open-access publisher sacks 31 editors amid fierce row over independence, Science, doi:10.1126/science.aac4629
Espeso, YouTube expands fact-checking to US, pledges $1M for IFCN
Faisal, Shah, Hussain, Potential use of azithromycin alone and in combination with ivermectin in fighting against the symptoms of COVID-19. The Professional, Medical Journal, doi:10.29309/tpmj/2021.28.05.5867
Fenter, media statement: article rejection: Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19, Frontiers in Pharmacology
Fihlani, Ivermectin: South African medics using unproven worm drug to treat Covid-19
Flccc Alliance, Dr, FLCCC weekly update -Dr Eric Osgood talks to
Flccc Alliance, FLCCC Alliance open letter to the investigators of the Oxford PRINCIPLE trial on ivermectin in COVID-19
Flccc Alliance, FLCCC weekly update -Dr. Jackie Stone & the Zimbabwe experience + Q&A
Flccc Alliance, None
Flccc Alliance, The WHO's denial of ivermectin: big science, disinformation and their impacts on human rights
Flccc Alliance, widespread disinformation campaign against ivermectin
Flccc Weekly Update, Kory, Kirsch, the proven efficacy of repurposed drugs for COVID-19
Fonseca, Sousa A De, Wolkoff, Moreira, Pinto et al., Risk of hospitalization for Covid-19 outpatients treated with various drug regimens in Brazil: comparative analysis, Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2020.101906
Fordham, Scandal of the suppressed case for ivermectin
Foundation, The Nobel prize in physiology or medicine
Franck, Trustwho, None
Freelon, Hanbury, Brazil's main COVID strategy is a cocktail of unproven drugs
Frieden, Drazen, Harrington, Mcmurray, Ware et al., Evidence for health decision making -beyond randomized controlled trials, doi:10.1056/nejmra1614394
Frketich, This could be a real game-changer
Frohman, Villemarette-Pittman, Rodriguez, Glanzman, Rugheimer et al., Application of an evidence-based out-patient treatment strategy for COVID-19: multidisciplinary medical practice principles to prevent severe disease, Journal of the Neurological Sciences, doi:10.1016/j.jns.2021.117463
Gallardo, Mariamé, Gence, Tilkin-Mariamé, Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth. Drug Design Development and Therapy, doi:10.2147/dddt.s172538
Gallardo, Teiti, Rochaix, Demilly, Jullien et al., Macrocyclic lactones block melanoma growth metastases development and potentiate activity of anti-BRAF V600 inhibitors, Clinical Skin Cancer, doi:10.1016/j.clsc.2016.05.001
Garcia, Mundaca, Gil, Leon, Malaga et al., Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial, Trials, doi:10.1186/s13063-021-05236-2
Garde, Scientists work toward an elusive dream: a simple pill to treat Covid-19
Garegnani, Madrid, Meza, Misleading clinical evidence and systematic reviews on ivermectin for COVID-19, BMJ Evidence-Based Medicine, doi:10.1136/bmjebm-2021-111678
Gates, Gates, The year global health went local
Gautret, Lagier, Parola, Hoang, Meddeb et al., Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.105949
Gavura, Ivermectin is the new hydroxychloroquine
Gittins, Bill Gates predicts when the next pandemic will arrive
Gjerstad, Oterholm, Bill Gates and Jeffrey Epstein met with Nobel Committee chair
Gold, Okyay, Licht, Hurley, Investigation of Long COVID prevalence and its relationship to Epstein-Barr virus reactivation, Pathogens, doi:10.3390/pathogens10060763
Gonzales, Coming soon: experts' findings on use of ivermectin to treat
Gordo, Weiland, García, Choperena, Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications. Radiología (English Edition), doi:10.1016/j.rxeng.2020.11.002
Gordon, Letter: government must cut the red tape restrictions on ivermectin
Gostin, Global health law: health in a global community, SSRN Electronic Journal
Gostin, Wiley, Public health law: power, duty, restraint, doi:10.1525/j.ctv1wxsrj
Griffin, Brennan-Rieder, Ngo, Kory, Confalonieri et al., The importance of understanding the stages of COVID-19 in treatment and trials, Aids Reviews, doi:10.24875/aidsrev.200001261
Grolle, Hackenbroch, Interview with epidemiologist Tom Jefferson: 'A whole industry is waiting for a pandemic
Guerrero, Bravo, Muñoz, Ardila, Guerrero, COVID-19: The ivermectin African enigma. Colombia Médica, doi:10.25100/cm.v51i4.4613
Gullino, Entidades médicas pedem banimento do uso de cloroquina e ivermectina contra Covid-19
Głuchowska, Dzieciątkowski, Sędzikowska, Zawistowska-Deniziak, Młocicki, The new status of parasitic diseases in the COVID-19 pandemic-risk factors or protective agents?, Journal of Clinical Medicine, doi:10.3390/jcm10112533
Hackethal, How molnupiravir moved to the head of the 'COVID pill' pack
Hariyanto, Halim, Gunawan, Kurniawan, Ivermectin and outcomes from Covid-19 pneumonia: a systematic review and meta-analysis of randomized clinical trial studies, Reviews in Medical Virology, doi:10.1002/rmv.2265
Hashimoto, Messerli, Sudo, Maruta, Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines, Drug Discov Ther
Hegazy, Alghamdi, Shouman, Hegazy, Mass chemoprophylaxis with ivermectin against COVID-19 pandemic: review and authors' perspective, Acta Scientific Medical Sciences
Heita, Dr, Itula advocates for ivermectin to deal with COVID, says it's no time for politics
Henderson, Judge orders hospital to give COVID patient ivermectin
Herbeck, After judge orders hospital to use experimental Covid-19 treatment, woman recovers
Herbeck, Judge orders Batavia hospital to treat coronavirus patient with ivermectin
Heredia, Médico puertoplateño logra mejorías en pacientes con COVID-19 al utilizar fármaco ivermectin
Herman, Chomsky, Manufacturing consent: the political economy of the mass media
Hill, Abdulamir, Ahmed, Asghar, Babalola et al., Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection, doi:10.21203/rs.3.rs-148845/v1
Hirschhorn, Pandemic Blunder: Fauci and Public Health Blocked Early Home COVID Treatment
Hoeksma, Private equity firm CVC Capital Partners invests in System C
Hope, Big Pharma uses Big Tobacco's strategy to defeat ivermectin
Hope, Is ivermectin the new penicillin? Desert Review
Hope, Ivermectin for the World
Hope, Ivermectin wins landmark court battle
Horowitz, Horowitz, WHO data: Ivermectin reduces COVID mortality by 81%. Also WHO: We still don't recommend it
Huet, Paun, Meet the world's most powerful doctor: Bill Gates
Irvin, Louden, UMN receives USD 1.5 million for COVID-19 treatment trial
Jagiasi, Nasa, Chanchalani, Ahmed, Kumar et al., Variation in therapeutic strategies for the management of severe COVID-19 in India -a nationwide cross-sectional survey, International Journal of Clinical Practice, doi:10.1111/ijcp.14574
Jaswal, Who killed ivermectin? Herald of Goa
Jimenez, Ivermectin and Covid-19: how a cheap antiparasitic became political
Jones, Fordham, Promising treatment options
Joseph, COVID-19: ivermectin tablets to be distributed among Uttarakhand residents
Juarez, Schcolnik-Cabrera, Dominguez-Gomez, Chavez-Blanco, Diaz-Chavez et al., Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug, Cancer Chemotherapy and Pharmacology, doi:10.1007/s00280-020-04041-z
Kaila, Mäkinen, Finland had a patent-free COVID-19 vaccine nine months ago -but still went with Big Pharma
Kapoor, Panda, Mohanty, Pharmacotherapy for COVID-19: A Ray of Hope, doi:10.5772/intechopen.97012
Karale, Bansal, Makadia, Tayyeb, Khan et al., A meta-analysis of mortality need for ICU admission, use of mechanical ventilation and adverse effects with ivermectin use in COVID-19 patients, medRxiv, doi:10.1101/2021.04.30.21256415
Karvanen, Study design in causal models, Scandinavian Journal of Statistics
Karvanen, Tikka, Hyttinen, Do-search: a tool for causal inference and study design with multiple data sources, Epidemiology, doi:10.1097/ede.0000000000001270
Kelly, A huge win for ivermectin -I speak with Alan Jones on Sky on this, Sky News
Kenup Foundation, Governments spent at least €93bn on COVID-19 vaccines and therapeutics during the last 11 months
Kern, Schöning, Chaccour, Hammann, Modeling of SARS-CoV-2 treatment effects for informed drug repurposing, Frontiers in Pharmacology, doi:10.3389/fphar.2021.625678
Khan, Khan, Debnath, Nath, Mahtab et al., Ivermectin treatment may improve the prognosis of patients with COVID-19. Archivos de Bronconeumología, doi:10.1016/j.arbres.2020.08.007
Khan, Khan, Debnath, Nath, Mahtab et al., Reply to "Ivermectin treatment may improve the prognosis of patients with COVID-19, Archivos de Bronconeumología, doi:10.1016/j.arbres.2020.12.013
Kim, Choi, Kim, Lee, The PAK1-Stat3 signaling pathway activates IL-6 gene transcription and human breast cancer stem cell formation, Cancers, doi:10.3390/cancers11101527
Kirsch, If you can prove that the NIH and WHO got their treatment guidelines right, you could win $2M
Klepáč, Pořád Nechápu, co se tu děje, říká brněnský primář Rezek
Klepáč, Rezek, Po první stovce pacientů cítíme, že ivermektin pomáhá
Klostermann, Streit, Zulassung von Corona-Mittel
Kluibenschädl, Ivermectin, Hochwirksam gegen Corona, aber von WHO & Mainstream bekämpft
Koch, How Koch is fighting COVID-19
Koch, Letter from Charles Koch Foundation and Charles Koch Institute on COVID-19 Pandemic
Kodama, Kodama, Newberg, Katayama, Kobayashi et al., In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.1705441114
Koenig, Masters, Buyout firm's offshore secrets
Kory, Kanne, SARS-CoV-2 organising pneumonia: 'Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?, BMJ Open Respiratory Research, doi:10.1136/bmjresp-2020-000724
Kory, Meduri, Iglesias, Varon, Berkowitz et al., Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19, doi:10.31219/osf.io/wx3zn
Kory, Meduri, Iglesias, Varon, Marik, Clinical and scientific rationale for the "MATH+" hospital treatment protocol for COVID-19, Journal of Intensive Care Medicine, doi:10.1177/0885066620973585
Kory, Meduri, Varon, Iglesias, Marik, Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19, American Journal of Therapeutics
Krolewiecki, Lifschitz, Moragas, Travacio, Valentini et al., Antiviral effect of high-dose ivermectin in adults with COVID-19: a proof-of-concept randomized trial, EClinicalMedicine, doi:10.1016/j.eclinm.2021.100959
Krumholz, Ross, Presler, Egilman, What have we learnt from Vioxx?, BMJ, doi:10.1136/bmj.39024.487720.68
Kyriakides, Answer for question E-002335/20
Lancet, What has the Gates Foundation done for global health? The Lancet, doi:10.1016/s0140-6736(09)60885-0
Lawrie, Ivermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance
Lawrie, Ivermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance
Leake, Dr, Peter McCullough Interview
Lee, Use of the anti-parasitic drug ivermectin to treat breast cancer, Oncology Times, doi:10.1097/01.cot.0000751988.88253.c3
Lenze, Mattar, Zorumski, Stevens, Schweiger et al., Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19, JAMA, doi:10.1001/jama.2020.22760
Li, Li, Desiderio, Zhan, SILAC quantitative proteomics analysis of ivermectin-related proteomic profiling and molecular network alterations in human ovarian cancer cells, Journal of Mass Spectrometry, doi:10.1002/jms.4659
Li, Li, Wang, Cao, Zhan, Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine, EPMA Journal, doi:10.1007/s13167-020-00224-z
Li, Miao, Li, Zhang, Kainov et al., Ivermectin effectively inhibits hepatitis E virus replication requiring the host nuclear transport protein importin a1, Archives of Virology, doi:10.1007/s00705-021-05096-w
Li, Warren Buffett gives away another USD 4.1 billion, resigns as trustee at
Li, Zhan, Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes, EPMA Journal, doi:10.1007/s13167-020-00209-y
Lind, Lovegrove, Geller, Uyeki, Datta et al., Increase in outpatient ivermectin dispensing in the US during the COVID-19 pandemic: a cross-sectional analysis, Journal of General Internal Medicine, doi:10.1007/s11606-021-06948-6
Liu, Fang, Sun, Liu, Anthelmintic drug ivermectin inhibits angiogenesis growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress, Biochemical and Biophysical Research Communications, doi:10.1016/j.bbrc.2016.10.064
Liu, Liang, Chen, Wang, Qu et al., Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells, Bioscience Reports, doi:10.1042/bsr20192489
Liu, Zhang, Cheng, Zhu, Xu, Progress in understanding the molecular mechanisms underlying the antitumour effects of ivermectin. Drug Design Development and Therapy, doi:10.2147/dddt.s237393
Lorigo, The Law Office of Ralph C
Loué, Fardeau, Ivermectin and COVID-19 in care home: case report, Journal of Infectious Diseases and Epidemiology, doi:10.23937/2474-3658/1510202
Lowe, In the pipeline: ivermectin as a COVID-19 therapy
Lpp, Channel, HOR COH Hearing IVERMECTIN
López-Medina, López, Hurtado, Dávalos, Ramirez et al., Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19, JAMA, doi:10.1001/jama.2021.3071
Machanick, Ivermectin: COVID-19 miracle cure or cruel hoax? ResearchGate, doi:10.13140/RG.2.2.13641.06249
Macleod, Assessing the strenght of the five filters today
Magro, Dr, Cynthia Magro explains her new paper
Magro, Mulvey, Kubiak, Mikhail, Suster et al., Severe COVID-19: a multifaceted viral vasculopathy syndrome, Annals of Diagnostic Pathology, doi:10.1016/j.anndiagpath.2020.151645
Mahmud, Rahman, Alam, Ahmed, Kabir et al., Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial, Journal of International Medical Research, doi:10.1177/03000605211013550
Mahpar, Clinic raided for offering ivermectin to Covid-19 patients
Malpani, Baker, Kamal-Yanni, Is the Gates Foundation addressing or reinforcing systemic problems raised by COVID-19? Health Policy Watch
Marik, a guide to the management of COVID-19
Marks, Lessons from corporate influence in the opioid epidemic: toward a norm of separation, Journal of Bioethical Inquiry, doi:10.1007/s11673-020-09982-x
Martinek, Hrozit pokutou je šokující, strhali poslanci
Maudrux, Ivermectin: the dark side of decisions
Maudrux, Ivermectine: le côté obscur des décisions
Mayer, The Koch Brothers' Covert Ops
Mcafee, Mialon, Mialon, Do sunk costs matter? Economic Inquiry, doi:10.1111/j.1465-7295.2008.00184.x
Mccoy, Kembhavi, Patel, Luintel, The Bill & Melinda Gates Foundation's grant-making programme for global health, The Lancet, doi:10.1016/s0140-6736(09)60571-7
Mccullough, Alexander, Armstrong, Arvinte, Bain et al., Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19), Reviews in Cardiovascular Medicine, doi:10.31083/j.rcm.2020.04.264
Mcdermid, signs USD 1.2 bln deal for 1.7 mln courses of Merck's experimental COVID-19 drug
Mcginley, Supporters tout anti-parasite drug as covid-19 treatment, but skeptics call it the 'new hydroxychloroquine
Mcguire, New study to test drugs for early COVID-19 infection
Mcmillan, Chetty, Alternative therapy options for COVID-19 with Dr Shankara Chetty
Medicalupdateonline, discussion with Dr Jackie Stone -full interview
Medicalupdateonline, discussion with Dr. Jackie Stone: the impact of ivermectin use in Zimbabwe
Melo Gd De, Lazarini, Larrous, Feige, Kornobis et al., Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin, EMBO Molecular Medicine, doi:10.15252/emmm.202114122
Melotti, Mas, Kuciak, Lorente-Trigos, Borges et al., The river blindness drug ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer, doi:10.15252/emmm.201404084
Mendez, of M Medical School receives USD 1.5M to launch nation's first ivermectin COVID-19 treatment clinical trial
Merck, Co, Msd, Merck statement on ivermectin use during the COVID-19 pandemic
Merck, Co, Msd, investigational oral therapeutic for the treatment of COVID-19
Merino, Borja, Lopez, Ochoa, Clark et al., Ivermectin and the odds of hospitalization due to COVID-19: evidence from a quasi-experimental analysis based on a public intervention in Mexico City, doi:10.31235/osf.io/r93g4
Mikhailova, Government sets up a new taskforce to create a Covid super pill, Daily Mail
Mohamed, The People's Voice with Shabnam Palesa Mohamed -18th
Mohamed, The people's voice with Shabnam Palesa Mohamed
Mohfw, Goi, Comprehensive guidelines for management of COVID-19 patients
Mokhtari, Mohraz, Gouya, Tabar, Tabrizi et al., Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting, International Immunopharmacology, doi:10.1016/j.intimp.2021.107636
Molento, Ivermectin against COVID-19: the unprecedented consequences in Latin America, One Health, doi:10.1016/j.onehlt.2021.100250
Mookim, The world loses under Bill Gates' vaccine colonialism
Mordani, DGHS drops ivermectin, doxycycline from Covid-19 treatment; ICMR rules unchanged
Morgenstern, Redondo, Olavarria, Rondon, Roca et al., Retrospective cohort study of ivermectin as a SARS-CoV-2 pre-exposure prophylaxis method in healthcare workers, doi:10.1101/2021.04.10.21255248
Mourya, Thakur, Hada, Kulshreshtha, Sharma, Comparative analytical study of two different drug regimens in treatment of Covid 19 positive patients in Index Medical College Hospital and Research Center, International Journal of Health and Clinical Research
Mudassar, Shen, Neill, Hau, Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas, Journal of Experimental & Clinical Cancer Research, doi:10.1186/s13046-020-01724-6
Murchu, Spillane, Byrne, Neill, Harrington et al., Interventions in an ambulatory setting to prevent progression to severe disease in patients with COVID-19: a systematic review, Annals of Pharmacotherapy, doi:10.1177/10600280211028242
Naggie, ACTIV-6: COVID-19 study of repurposed medications
Nambara, Masuda, Nishio, Kuramitsu, Tobo et al., Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer, Oncotarget, doi:10.18632/oncotarget.22587
Nappi, Aguda, Nakouzi, Lelj-Garolla, Beraldi et al., Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models, Journal of Clinical Investigation, doi:10.1172/jci130819
Narayanan, Gates, relationship with WHO explained
Nardelli, Zangrillo, Sanchini, Likhvantsev, Yavorovskiy et al., Crying wolf in time of corona: the strange case of ivermectin and hydroxychloroquine. Is the fear of failure withholding potential life-saving treatment from clinical use? Signa Vitae, doi:10.22514/sv.2021.043
Ndebele, Zimbabwe approves use of ivermectin to treat Covid-19
Ndlovu, Zimbabwe to allow use of ivermectin for research
Neves, The lawyer who won the ivermectin battle for South Africans
Newmark, Wikipedia
Niaee, Gheibi, Namdar, Allami, Zolghadr et al., Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial, doi:10.21203/rs.3.rs-109670/v1
Nishio, Sugimachi, Goto, Wang, Morikawa et al., Dysregulated YAP1/TAZ and TGF-b signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.1517188113
Nuki, Pfizer is testing a pill that, if successful, could become first-ever home cure for COVID-19
Offord, Frontiers pulls special COVID-19 issue after content dispute
Offord, Frontiers removes controversial ivermectin paper pre-publication
Okumuş, Demirtürk, Çetinkaya, Güner, Avcı İsmail et al., Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients, BMC Infectious Diseases, doi:10.1186/s12879-021-06104-9
Olavarría, TratamientoTemprano -Inicio
Olavarría, la mortalidad fue 4 IVM vs 11 control, pero ahí lo muestran INVERTIDO, castigando a la Ivermectina y concluyen no beneficio
Olson, Controversial ivermectin added to University of Minnesota COVID-19 drug trial
Padhy, Mohanty, Das, Meher, Therapeutic potential of ivermectin as add on treatment in COVID 19: a systematic review and meta-analysis, Journal of Pharmacy & Pharmaceutical Sciences, doi:10.18433/jpps31457
Pahisa, Hospital Clínic prova l'eficàcia de la ivermectina per la covid
Panayides, Why aren't we treating Covid? Cyprus Mail
Pannozzo, What's the deal with ivermectin and COVID? Halifax Examiner
Peers, Histamine Intolerance (HIT), Mast Cell Activation Syndrome (MCAS) and Long Covid
Peng, Mohd, Yusoff, Abdullah, Govindarajoo, Letter: use of ivermectin against Covid-19: reply to Health DG
Penston, Statistics-based research -a pig in a poke? Journal of Evaluation in Clinical Practice, doi:10.1111/j.1365-2753.2011.01717.x
Periago, Paraguay is doubling the bet with a deworming campaign to treat and prevent NTDs among school children
Pfeiffer, Stories by Mary Beth Pfeiffer
Pfeiffer, Top Yale doctor/researcher: 'ivermectin works,' including for long-haul COVID
Pfeiffer, When nothing else works, judges are siding with ivermectin
Piller, Private research funders court controversy with billions in secretive investments, Science, doi:10.1126/science.aaw2881
Politifact, New grant will help PolitiFact grow
Popp, Stegemann, Metzendorf, Kranke, Meybohm et al., Ivermectin for preventing and treating COVID-19, Cochrane Database of Systematic Reviews, doi:10.1002/14651858.cd015017
Portmann-Baracco, Alberti, Accinelli, Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19. Archivos de Bronconeumología
Porybný, SÚKL hrozí Právu pokutou až půl milionu za články o ivermektinu
Pr, Babalola, ils jouent avec la politique, pas vraiment concernés par les patients
Pradhan, Odisha to buy 7.2 lakh ivermectin tabs for patients in isolation
Qureshi, Mir, Naz, Nur-E-Alam, Ahmed et al., Mechanistic insights into the inhibitory activity of FDA approved ivermectin against SARS-CoV-2: old drug with new implications, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1906750
Rabben, Andersen, Ianevski, Olsen, Kainov et al., Computational drug repositioning and experimental validation of ivermectin in treatment of gastric cancer, Frontiers in Pharmacology, doi:10.3389/fphar.2021.625991
Rafaeli, da Unicamp faz desafio e ganha aula gratuita
Rajter, Sherman, Fatteh, Vogel, Sacks et al., in Hospitalized Patients with COVID19, doi:10.1101/2020.06.06.20124461
Ravelo, Unitaid chief: we need to 'double down' on R&D for COVID-19 treatment
Reich, Nechápu, proč se bojíme použít staré léky na nové nemoci
Reis, Santos, Repurposed approved therapies for outpatient treatment of patients with early-onset COVID-19 and mild symptoms
Rivers, Faith in medicine again': doctors, patients going off-label to survive COVID
Roche, Connor, Murphy, Ivermectin in dermatology: why it 'mite' be useless against COVID-19, Clinical and Experimental Dermatology, doi:10.1111/ced.14704
Rochwerg, Siemieniuk, Agoritsas, Lamontagne, Askie et al., A living WHO guideline on drugs for COVID-19, BMJ, doi:10.1136/bmj.m3379
Roman, Burela, Pasupuleti, Piscoya, Vidal et al., Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials, doi:10.1101/2021.05.21.21257595v2.full.pdf
Roman, Burela, Pasupuleti, Piscoya, Vidal et al., Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials, Clinical Infectious Diseases, doi:10.1093/cid/ciab591
Rowell, Facebook's new fact-checking service are Koch-funded climate deniers
Royes, Letter of the day: why the resistance to ivermectin? Jamaica Gleaner
Saha, Raihan, The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2, Structural Chemistry, doi:10.1007/s11224-021-01776-0
Saint-Mont, Tu, Randomization does not help much, comparability does, PLOS ONE, doi:10.1371/journal.pone.0132102
Samaha, Mouawia, Fawaz, Hassan, Salami et al., Effects of a single dose of ivermectin on viral and clinical outcomes in asymptomatic SARS-CoV-2 infected subjects: a pilot clinical trial in Lebanon, Viruses, doi:10.3390/v13060989
Saunders-Hastings, Give and take
Schellack, Padayachee, Schellack, Ivermectin in the treatment of COVID-19 -friend or foe? South African General Practitioner, doi:10.36303/sagp.2021.2.1.0055
Schirrmacher, Ivermectin-based treatments could save many lives worldwide
Schulz, Rollwage, Dolan, Fleming, Dogmatism manifests in lowered information search under uncertainty, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2009641117
Schumaker, Hydroxychloroquine and other 'miracle cures' continue to fuel Brazil's outbreak
Schwab, Bill Gates's charity paradox
Schwab, Covid-19 trust, and Wellcome: how charity's pharma investments overlap with its research efforts, BMJ, doi:10.1136/bmj.n556
Schwab, While the poor get sick, Bill Gates just gets richer
Schwarz, Bonhotal, The fate of ivermectin in manure composting
Scola, A CMD special report on ALEC's funding and spending
Seet, Quek, Ooi, Sengupta, Lakshminarasappa et al., Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: an open-label randomized trial, International Journal of Infectious Diseases, doi:10.1016/j.ijid.2021.04.035
Seftel, Boulware, Prospective cohort of Fluvoxamine for early treatment of Coronavirus Disease 19, Open Forum Infectious Diseases, doi:10.1093/ofid/ofab050
Seidenath, Wirkstoff Ivermectin: CSU-Fraktion will Therapieforschung für COVID-19 ausweiten
Seymour, Bauchner, Golub, COVID-19 Infection -preventing clinical deterioration, JAMA. December, doi:10.1001/jama.2020.21720
Sgaier, Huang, Charles, The case for causal AI
Shahbaznejad, Davoudi, Eslami, Markowitz, Navaeifar et al., Effect of ivermectin on COVID-19: a multicenter double-blind randomized controlled clinical trial, Clinical Therapeutics, doi:10.1016/j.clinthera.2021.04.007
Sharmeen, Skrtic, Sukhai, Hurren, Gronda et al., The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells, Blood. November, doi:10.1182/blood-2010-01-262675
Shekhar, HCQ to ivermectin: why India has got it wrong in Covid-19 treatment
Shouman, Hegazy, Nafae, Sileem, Use of ivermectin as a potential chemoprophylaxis for COVID-19 in Egypt: a randomised clinical trial, Journal of Clinical and Diagnostic Research
Shouman, Prophylactic ivermectin in COVID-19 contacts
Shukla, Covid, -19: states ignore WHO recommendation on Ivermectin, here's what doctor who wrote white paper on the drug has to say
Sia, Mensah, Opoku-Agyemang, Folitse, Darko, Mechanisms of ivermectin-induced wound healing, BMC Veterinary Research, doi:10.1186/s12917-020-02612-z
Siedner, Ivermectin for the treatment of COVID-19 disease: Too good to pass up or too good to be true?, Open Forum Infectious Diseases, doi:10.1093/ofid/ofab318
Siemieniuk, Bartoszko, Ge, Zeraatkar, Izcovich et al., Drug treatments for COVID-19: living systematic review and network meta-analysis, BMJ, doi:10.1136/bmj.m2980
Sinkins, Sa, Karim, World Health Organisation's science council
Soto-Becerra, Culquichicón, Hurtado-Roca, Araujo-Castillo, Real-world effectiveness of hydroxychloroquine, azithromycin and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru, SSRN Electronic Journal, doi:10.2139/ssrn.3710623
Sourcewatch, Koch, None
Spallitta, WO2019136211A1 -Treating autoimmune disorders with ivermectin
Sridhar, King, US decision to pull out of World Health Organization, BMJ, doi:10.1136/bmj.m2943
Stone, Gill, Zimbabwe rollout of silver and ivermectin protocol
Strnad, Brzy zveřejníme čísla, říká primář od svaté Anny
Struhárňanská, Hložník, Obviňujú nás, že zabíjame pacientov. Ivermektín ale nezaberá
Sulaiman, Aljuhani, Dossari, Alshahrani, Alharbi et al., Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a multicenter propensity score matched study, doi:10.21203/rs.3.rs-400565/v1
Suzman, Why we focus on vaccine equity
Syed, CVC raises 4.6 billion Euros for second long-term fund
Syed, UK clinical trial for a nasal spray for COVID -amazing results
Sánchez, Sacan artillería médica contra Covid-19
Tan, Source: Health Ministry to handle complaint against minister, D-G for not using Ivermectin to treat Covid-19
Tang, Hu, Wang, Yao, Zhang et al., Ivermectin, a potential anticancer drug derived from an antiparasitic drug, Pharmacological Research, doi:10.1016/j.phrs.2020.105207
Tarazona, Martínez, Martínez, Anadón, Environmental impact assessment of COVID-19 therapeutic solutions. A prospective analysis, Science of The Total Environment, doi:10.1016/j.scitotenv.2021.146257
Ternelli, Ivermectina contro COVID, capsule galeniche in Farmacia
Thakur, Vaccine efficacy vs harms
Thaldar, Ivermectin and the rule of law. South African Journal of Bioethics and Law, doi:10.7196/sajbl.2021.v14i2.763
The, Alliance, The Bill and Melinda Gates Foundation
The, Group, Dexamethasone in hospitalized patients with Covid-19, New England Journal of Medicine, doi:10.1056/nejmoa2021436
Thomas, Zimbabwe, the future of news is messaging
Tikka, Karvanen, Identifying causal effects with the R package causaleffect, Journal of Statistical Software, doi:10.18637/jss.v076.i12
Tipthara, Kobylinski, Godejohann, Hanboonkunupakarn, Roth et al., Identification of the metabolites of ivermectin in humans, Pharmacology Research & Perspectives, doi:10.1002/prp2.712
Touraine, Resolution n°3: approval of the 2021 Unitaid budget
Tsegay, Adeyemi, Gniffke, Sather, Walker et al., A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2, doi:10.1101/2021.04.08.439071
Turkia, A timeline of ivermectin-related events in the COVID-19 pandemic
Turkia, A timeline of ivermectin-related events in the COVID-19 pandemic, ResearchGate, doi:10.13140/RG.2.2.12768.20488
Turkia, FLCCC Alliance MATH+ ascorbic acid and I-MASK+ ivermectin protocols for COVID-19 -a brief review, SSRN Electronic Journal, doi:10.2139/ssrn.3723854
Turkia, The History of Methylprednisolone, Ascorbic Acid, Thiamine, and Heparin Protocol and I-MASK+ Ivermectin Protocol for COVID-19, doi:10.7759/cureus.12403
Turton, I base my comments on science': emeritus professor Robert Clancy defends hydroxychloroquine stance
Turton, It's crystal clear': Professor Robert Clancy backs ivermectin as a COVID-19 treatment
Unitaid, Medicines Patent Pool and Unitaid respond to access efforts for COVID-19 treatments and technologies
Unitaid, None
Unitaid, part of the World Health Organization funding ivermectin research targeting COVID-19 led by British expert
Valente, Peña, govt allocates P22M for ivermectin clinical trials
Vega, Ivermectin or fluvoxamine for outpatient treatment of COVID-19, Medscape
Villar, Confalonieri, Pastores, Meduri, Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019. Critical Care Explorations, doi:10.1097/cce.0000000000000111
Vizcarra, el uso de ivermectina pese a falta de evidencia científica
Vs, cancer. The Foolishness of God
Wadvalla, Covid-19: ivermectin's politicisation is a warning sign for doctors turning to orphan treatments, BMJ, doi:10.1136/bmj.n747
Wang, Jin, Wu, Zhao, Liang et al., Organizing pneumonia of COVID-19: time-dependent evolution and outcome in CT findings, PLOS ONE, doi:10.1371/journal.pone.0240347
Wang, Levi, Ellis, Hill, Minimum manufacturing costs national prices and estimated global availability of new repurposed therapies for COVID-19, doi:10.1101/2021.06.01.21258147
Wang, Xu, Wan, Hu, Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress, Biochemical and Biophysical Research Communications, doi:10.1016/j.bbrc.2018.02.063
Wehbe, Wehbe, Iratni, Pintus, Zaraket et al., Repurposing ivermectin for COVID-19: molecular aspects and therapeutic possibilities, Frontiers in Immunology, doi:10.3389/fimmu.2021.663586
Who African Region, for the virus. The medication is used to treat parasitic worms
Williams, Pfizer, oral drug to stop coronavirus could be ready next year
Wiseman, Kory, Al, Possible clustering and/or drug switching confounding obscures up to 56% reduction of symptom persistence by ivermectin, doi:10.31219/osf.io/bvznd
Wu, Xie, Longitudinal CT findings in COVID-19 pneumonia: case presenting organizing pneumonia pattern, Radiology: Cardiothoracic Imaging, doi:10.1148/ryct.2020200031
Yagisawa, Foster, Ōmura, Global trends in clinical studies of ivermectin in COVID-19, Japanese Journal of Antibiotics
Yeung, mean? CNN
Yuce, Cicek, Inan, Dag, Kurkcuoglu et al., Repurposing of FDA-approved drugs against active site and potential allosteric drug binding sites of COVID-19 main protease, Proteins, doi:10.1002/prot.26164
Zaheer, Pal, Abbas, Torres, Del, COVID-19 and Ivermectin: Potential threats associated with human use, Journal of Molecular Structure, doi:10.1016/j.molstruc.2021.130808
Zaidi, Dehgani-Mobaraki, The mechanisms of action of ivermectin against SARS-CoV-2: an evidence-based clinical review article, The Journal of Antibiotics, doi:10.1038/s41429-021-00430-5
Zaitchik, How Bill Gates impeded global access to Covid vaccines
Zhan, Li, The anti-cancer effects of anti-parasite drug ivermectin in ovarian cancer, doi:10.5772/intechopen.95556
Zhang, Qin, Zhu, Hong, Xu et al., Ivermectin augments the in vitro and in vivo efficacy of cisplatin in epithelial ovarian cancer by suppressing Akt/mTOR signaling, The American Journal of the Medical Sciences, doi:10.1016/j.amjms.2019.11.001
Zhang, Song, Ci, Ju, Li, Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice, Inflammation Research, doi:10.1007/s00011-008-8007-8
Zhang, Zhang, Liu, Liu, Xu et al., Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway, Cell Proliferation, doi:10.1111/cpr.12543
Zhang, Zhang, Zhai, Zhao, Wang et al., Inhibition of TMEM16A Ca2+-activated Clchannels by avermectins is essential for their anticancer effects, Pharmacological Research, doi:10.1016/j.phrs.2020.104763
Zhu, Li, Zhou, Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage, Biochemical and Biophysical Research Communications, doi:10.1016/j.bbrc.2017.08.097
Zimmer, A pill to treat Covid-19? The U.S. is betting on it
Õmura, Crump, The life and times of ivermectin -a success story, Nature Reviews Microbiology, doi:10.1038/nrmicro1048
Ōmura, Crump, Ivermectin and malaria control, Malaria Journal, doi:10.1186/s12936-017-1825-9
Ōmura, Crump, Ivermectin: panacea for resource-poor communities?, Trends in Parasitology, doi:10.1016/j.pt.2014.07.005
Šopfová, Plesník, Ivermektin je slibný lék. Využijme ho, říká poslanec bavorského sněmu Reiss
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit